QSAR and molecular modelling studies on B-DNA recognition of minor groove binders

European Journal of Medicinal Chemistry

Volumn 38, Issue 2, 2003, Pages 141-155

  De Oliveira, André Mauricio ^a   Custódio, Flávia Beatriz ^a   Donnici, Cláudio Luis ^a   Montanari, Carlos Alberto ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

CoMFA; Comparative QSAR; Leishmaniasis; Pneumocystis carinii pneumonia

Indexed keywords

1,1 DICHLORO 2,2 BIS(4 CHLOROPHENYL)ETHANE; 4 [5 (4 METHYL 1 PIPERAZINYL)[2,5' BI 1H BENZIMIDAZOL] 2' YL]PHENOL; 4',6 DIAMIDINO 2 PHENYLINDOLE; AROMATIC COMPOUND; DIMINAZENE ACETURATE; DNA B; FURAN; MAGNESIUM ION; PENTAMIDINE; POTASSIUM ION; SODIUM ION;

ANALYTIC METHOD; ARTICLE; DNA BINDING; DNA CONFORMATION; DNA DENATURATION; DNA DRUG COMPLEX; DRUG DNA BINDING; DRUG DNA INTERACTION; DRUG STRUCTURE; ENERGY; HYDROGEN BOND; MATHEMATICAL COMPUTING; MOLECULAR MECHANICS; MOLECULAR MODEL; MOLECULAR RECOGNITION; QUANTITATIVE STRUCTURE ACTIVITY RELATION; QUANTUM CHEMISTRY; SUBSTITUTION REACTION; VALIDATION PROCESS;

EID: 0037293074     PISSN: 02235234     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0223-5234(02)01419-8     Document Type: Article

References (43)

1. Basselin M.M., Badet Denisot A.M., Lawrence F., Robert Gero M. Exp. Parasitol. 85:1997;274.
2. Basselin M.M., Lawrence F., Robert Gero M. Biochem. J. 315:1996;631.
3. Walzer P.D. Lung biology in health and disease. Walzer P.D. Pneumocystis carinii Pneumonia. 2nd ed :1994;Marcel Dekker, New York. Revised and Expanded, v. 69.
4. Kandpal M., Tekwani B.L., Chauhan P.M.S., Bhaduri A.P. Life Sci. 59:1996;75.
5. Dirienzo A.G., Van der Host C., Finkelstein D.M., Frame P., Bozzette S.A., Tashima K.T. Aids Res. Human Retovir. 18:2002;89.
6. Silverman R.B. The Organic Chemistry of Drug Design and Drug Action. 1992;Academic Press, San Diego.
7. Caldas A.J., Silva D.R., Pereira C.C., Nunes P.M., Silva B.P., Silva A.A., Barral A., Costa J. M. Rev. Soc. Bras. Med. Trop. 28:1995;405.
8. Albrecht H. AIDS. 12:1998;2225.
9. Carvalho P.B., Arribas M.A.G., Ferreira E.I. Br. J. Pharm. Sci. 36:2000;69.
10. Matesoi D., Kittler I., Bell A., Unger E., Lober G. Biochem. Mol. Biol. Int. 36:1996;123.
11. Edwards K.J., Jenkins T.C., Neidle S. Biochemistry. 31:1992;7104.
12. Montanari C.A., Tute M.S., Beezer A.E., Mitchell J.C. J. Comp.-Aid. Mol. Des. 10:1996;67.
13. Bornstein R.S., Yarbro J.W. J. Surg. Oncol. 2:1970;393.
14. Gutteridge W.E. J. Protozool. 16:1969;306.
15. Bachrach U., Brem S., Wertman S.B., Schnur L.F., Greenblatt C.C. Exp. Parasitol. 48:1979;464.
16. Bitonti A.J., Dumont J.A., McCann P.P. Biochem. J. 237:1986;685.
17. Waring M. J. Mol. Pharmacol. 1:1965;1.
18. Kaplan H.G., Myers C.E. J. Pharmacol. Exp. Ther. 201:1977;554.
19. Dykstra C.C., Tidwell R.R. J. Protozool. 6:1991;78S.
20. Shapiro T.A., England P.T. Proc. Natl. Acad. Sci. USA. 87:1990;950.
21. Cohen N.C. Guidebook on Molecular Modeling in Drug Design. 1996;Academic Press.
22. Minasov G., Tereshko V., Egli M. J. Mol. Biol. 291:1999;83.
23. SYBYL 6.5 (MIPS3 - IRIX 6.2). 1998;Tripos Associates, St. Louis, MO, USA.
24. CORINA v.1.7, Computer-Chemie-Centrum, Universität Erlangen-Nürnberg, 1996.
25. MOPAC, v. 7.0 University of Indiana, Bloomington IN 47405.
26. MacroModel v. 5.5, Department of Chemistry, Columbia University, New York, NY 10027.
27. Weiner S.J., Kollman P.A., Case D.A., Singh U.C., Ghio C., Alagona G., Profeta S., Weiner P. J. Am. Chem. Soc. 106:1984;765.
28. Orozco M., Laughton C.A., Neidle S., Schwalbe C.H., Stevens M.F.G. Anti-Cancer Drug Des. 5:1990;243.
29. Montanari C.A., Trent J.O., Jenkins T. J. Braz. Chem. Soc. 9:1998;175.
30. Lavery R., Zakrzewska K., Pullman B. J. Biomol. Struct. Dyn. 3:1986;1155.
31. Brookhaven Data Bank, http://rutgers.rcsb.org/pdb.
32. Bernstein F.C., Koetzel T.F., Willians G.J.B., Meyer E.F., Brice M.D., Rodgers J.R., Kennard O., Shimanouchi K., Tasumi M.J. J. Mol. Biol. 112:1977;535.
33. Pullman B. Molecular mechanics of specificity in DNA - antitumour drug interactions. Advances in Drug Research. 18:1989;Academic Press, London.
34. S. Mazur, F.A. Tanious, D. Ding, A. Kumar, D.W. Boykin, I.J. Simpson, S. Neidle, W.D. Wilson, J. Mol. Biol. (2000) 321.
35. Blackburn G.M., Gait M.J., Gumpart R.I. Dynamics of nucleic acid structures. Blackburn G.M., Gait M.J. Nucleic Acids in Chemistry and Biology. 2nd ed :1996;Oxford University Press.
36. Andrews P.R., Craik D.J., Martin J.L. J. Med. Chem. 27:1984;1648.
37. Tsar(TM) v. 3.0, Oxford Molecular Ltd., UK, 1997.
38. Cramer R.D., Patterson D.E., Bunce J.D. J. Am. Chem. Soc. 110:1988;5959.
39. Czarny A., Boykin D.W., Wood A.A., Nunn C.M., Neidle S., Zhao M., Wilson D.W. J. Am. Chem. Soc. 117:1995;4716.
40. Jencks W.P. Hydrophobic forces. Catalysis in Chemistry and Enzymology. 1969;Dover Publisher, New York.
41. Neto M.O. Quim. Nova. 12:1989;248.
42. Francesconi I., Wilson W.D., Tanious F.A., Hall J.E., Bender B.C., Tidwell R.R., McCurdy D., Boykin D.W. J. Med. Chem. 42:1999;12.
43. Walzer P.D., Foy J., Runck J., Steele P., White M., Klein R.S., Otter B.A., Sundberg R.J. Ant. Agents Chemother. 38:1994;2572.